✨
AI Summary
- Discussing malignancy risk in RA patients.
- Analyzing data from biological or targeted synthetic DMARD initiators.
- Insights from a 5-year population-based cohort study.
Guests on This Episode
CK
Chung-Mao Kao
1 podcast appearance